Shuvo Roy

Last updated

Shuvo Roy
Born
Bangladesh [1]
NationalityAmerican
Alma materMount Union College
Case Western Reserve University
Known forCo-invention of an implantable artificial kidney, medical MEMS
Scientific career
FieldsBioengineering, Biomedical MEMS, Pediatric Devices
Institutions University of California, San Francisco
Doctoral advisor Mehran Mehregany

Shuvo Roy is an American scientist and engineer of South Asian descent. [1]

Contents

Early life and education

Roy received most of his education in Uganda, where his father worked as a public health physician. [1]

Roy later completed his education and earned his BS degree from University of Mount Union, Ohio in 1992. He then earned his MS degree in Electrical Engineering and Applied Physics from Case Western Reserve University in 1995. He went on to earn his PhD degree from the same school in 2001. [2]

Career

Roy has developed silicon nanopore membranes (SNM) to achieve high-efficiency blood ultrafiltration while selectively retaining specific solutes and serving as an immunoprotective barrier for encapsulated cells. The SNM are the fundamental underlying technology for the development of an implantable bioartificial kidney. [3]

Using this technology, he has shown feasibility for an implantable bioartificial pancreas (iBAP). Previous attempts to develop a bioartificial pancreas have been severely limited by insufficient mass transfer and a limited supply of beta cells, but Roy says that ultra-high hydraulic permeability characteristic of the SNM will enable appropriate mass transport (especially oxygen, glucose, and insulin) to achieve optimal beta cell performance, while the ultra-selective pore characteristic of the SNM enable unprecedented immunoisolation. Also the iBAP can utilize a human stem cell derived fully functional beta cell that provides and unlimited supply of beta cells. [4]

He is a founding member of the University of California, San Francisco Pediatric Device Consortium. [2]

Professional positions

Book chapters

Honors and awards

Related Research Articles

<span class="mw-page-title-main">Biomedical engineering</span> Application of engineering principles and design concepts to medicine and biology

Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in California, US

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. The replaced function does not have to be related to life support, but it often is. For example, replacement bones and joints, such as those found in hip replacements, could also be considered artificial organs.

<span class="mw-page-title-main">Tissue engineering</span> Biomedical engineering discipline

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can is considered as a field of its own.

Artificial kidney is often a synonym for hemodialysis, but may also refer to the other renal replacement therapies that are in use and/or in development. This article deals mainly with bioengineered kidneys/bioartificial kidneys that are grown from renal cell lines/renal tissue.

Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.

Marilyn Gist Farquhar was a pathologist and cellular biologist, Professor of Cellular and Molecular Medicine and Pathology, as well as the chair of the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, who previously worked at Yale University from 1973 to 1990. She has won the E. B. Wilson Medal and the FASEB Excellence in Science Award. She was married to Nobel Laureate George Emil Palade from 1970 to his death in 2008. Her research focuses on control of intracellular membrane traffic and the molecular pathogenesis of auto immune kidney diseases. She has yielded a number of discoveries in basic biomedical research including: mechanisms of kidney disease, organization of functions that attach cells to one another, and mechanisms of secretions.

<span class="mw-page-title-main">Tejal A. Desai</span> American Nanotechnologist (born 1972)

Tejal Ashwin Desai is Sorensen Family Dean of Engineering at Brown University. Prior to joining Brown, she was the Deborah Cowan Endowed Professor in the Department of Bioengineering and Therapeutic Sciences at University of California, San Francisco, Director of the Health Innovations via Engineering Initiative (HIVE), and head of the Therapeutic Micro and Nanotechnology Laboratory. She was formerly an associate professor at Boston University (2002–06) and an assistant professor at University of Illinois at Chicago (1998–2001). She is a researcher in the area of therapeutic micro and nanotechnology and has authored and edited at least one book on the subject and another on biomaterials.

Utkan Demirci is a tenured professor and a successful serial academic entrepreneur at Stanford University at the departments of Radiology and Electrical Engineering. He served as the Interim Division Chief and Director of the Canary Center at Stanford for Cancer Early Detection in the Department of Radiology.

<span class="mw-page-title-main">California Institute for Quantitative Biosciences</span>

The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.

<span class="mw-page-title-main">Sangeeta Bhatia</span> American nanotechnologist

Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.

<span class="mw-page-title-main">Gordana Vunjak-Novakovic</span> Serbian American engineer

Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.

<span class="mw-page-title-main">Albert Folch Folch</span> Spanish bioengineer (born 1966)

Albert Folch Folch is a Spanish/Catalan scientist, writer, and artist. He is currently a professor in the Department of Bioengineering at the University of Washington who is known for his research into Microfluidics and BioMEMS as well as his works of scientific art.

<span class="mw-page-title-main">Thorsten Walles</span> German university teacher

Thorsten Walles is a German general thoracic surgeon and professor at the University Hospital of Würzburg. He is known for his works in the field of trachea surgery and his research for early diagnosis of lung cancer.

<span class="mw-page-title-main">Nancy Allbritton</span> American biologist

Nancy Allbritton is a Professor of Bioengineering and the Frank & Julie Jungers Dean of the College of Engineering at the University of Washington. She was previously a Kenan Professor and Chair in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University.

John X. J. Zhang is a tenured professor at Thayer School of Engineering of Dartmouth College, and an investigator in the Dartmouth-Hitchcock Medical Center. Before joining Dartmouth, he was an associate professor with tenure in the Department of Biomedical Engineering at the University of Texas(UT Austin). He received his Ph.D. in electrical engineering from Stanford University, California in 2004, and was a research scientist in systems biology at the Massachusetts Institute of Technology (MIT) before joining the faculty at UT Austin in 2005. Zhang is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a recipient of the 2016 NIH Director's Transformative Research Award.

Laura Elizabeth Niklason is a physician, professor and internationally recognized researcher in vascular and lung tissue engineering. She is the Nicholas M. Greene Professor of Anesthesiology and Biomedical Engineering at Yale University and co-founder, chief executive officer and president of Humacyte, a regenerative medicine company developing bioengineered human tissues.

Ada Poon is a professor of electrical engineering at Stanford University. She is the principal investigator of Stanford Integrated Biomedical Systems Lab.

Jerome Schultz is an American bioengineering researcher, professor, and university administrator. He is a fellow of several national scientific societies and a member of the National Academy of Engineering. He has held professorships at the University of Michigan, the University of Pittsburgh, University of California, Riverside, and he is currently a Distinguished Professor of Biomedical Engineering at the University of Houston.

References

  1. 1 2 3 "Artificial kidney made by Indian American awaits human trials". Deccan Herald. IANS. 3 December 2010.
  2. 1 2 3 4 5 "UCSF Profiles - Shuvo Roy".
  3. Building an Implantable Artificial Kidney, NIH
  4. Implantable Bio-Artificial Pancreas (iBAP), NIH
  5. "NRIs in MIT's list". Hindustan Times. 6 January 2004.

Further reading